TS-022

· Taisho Pharmaceutical R&D Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TS-022, covering 2011-11-17 to 2011-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC) [Phase 2]